hotspot -WSS

hotspot

author：fashion 2025-10-03 00:03:59 - browse：28796

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： The United States must get value

hotspot

knowledge

WSS

ALS treatment from Biogen, Ionis fails in study

Police still searching for prisoner who escaped from NYC hospital

Free medical tuition alone isn't enough to close gaps in primary care

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Emergent cuts jobs, executive role in business shake

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

leisure time

hotspot

knowledge

Alkermes shareholders re

The White House hikes tariffs on plastic syringes made in China

Apple is now the first public company to be valued at $3 trillion

WuXi Biologics beefs up its lobbying operation

What does generative AI mean for health care? We asked experts

The best solution to the drug shortages problem

Novavax promises a turnaround & Lilly roils the obesity market

Wegovy’s successful heart trial raises vital question about weight loss

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wikipedia

Drastic changes should bring profitability, startup health insurers say

Oak Street deal isn't the answer to health care's woes

Obesity drug from Roche shows promise in early study

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Boston hospital trains restaurant workers on naloxone for overdoses

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

focus

hotspot

knowledge

focus